Literature DB >> 8298091

Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia.

P H Chan1, H Kamii, G Yang, J Gafni, C J Epstein, E Carlson, L Reola.   

Abstract

Using a mouse model with intraluminal blockade of the middle cerebral artery (MCA) which produced both cortical and striatal infarction, the effect that superoxide radicals have on cerebral infarction, local cerebral blood flow, and neurological deficits after 24 h of permanent focal cerebral ischemia in transgenic mice (Tg) overexpressing human CuZn-superoxide dismutase (SOD-1) was examined. There were no difference between SOD-1 Tg mice and non-Tg littermates observed in the infarct areas of brain slices, the infarct volume, the local cerebral blood flow, or the neurological deficits. These data suggest that pre-existing high levels of antioxidant enzyme failed to provide neuronal protection against permanent focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298091     DOI: 10.1097/00001756-199312000-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  27 in total

1.  Gene therapy using SOD1 protects striatal neurons from experimental stroke.

Authors:  Alexis S Davis; Heng Zhao; Guo Hua Sun; Robert M Sapolsky; Gary K Steinberg
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

2.  Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein.

Authors:  F Zhang; C Eckman; S Younkin; K K Hsiao; C Iadecola
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 3.  Neuronal death/survival signaling pathways in cerebral ischemia.

Authors:  Taku Sugawara; Miki Fujimura; Nobuo Noshita; Gyung Whan Kim; Atsushi Saito; Takeshi Hayashi; Purnima Narasimhan; Carolina M Maier; Pak H Chan
Journal:  NeuroRx       Date:  2004-01

Review 4.  Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke.

Authors:  Stephanie M Davis; Keith R Pennypacker
Journal:  Neurochem Int       Date:  2016-12-30       Impact factor: 3.921

Review 5.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 6.  Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection.

Authors:  Hai Chen; Hideyuki Yoshioka; Gab Seok Kim; Joo Eun Jung; Nobuya Okami; Hiroyuki Sakata; Carolina M Maier; Purnima Narasimhan; Christina E Goeders; Pak H Chan
Journal:  Antioxid Redox Signal       Date:  2011-01-09       Impact factor: 8.401

Review 7.  Oxidative stress and neuronal death/survival signaling in cerebral ischemia.

Authors:  Atsushi Saito; Carolina M Maier; Purnima Narasimhan; Tatsuro Nishi; Yun Seon Song; Fengshan Yu; Jing Liu; Yong-Sun Lee; Chikako Nito; Hiroshi Kamada; Robert L Dodd; Lily B Hsieh; Benjamin Hassid; Esther E Kim; Maricela González; Pak H Chan
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

8.  Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice.

Authors:  Nobuo Noshita; Taku Sugawara; Takeshi Hayashi; Anders Lewén; Ghezal Omar; Pak H Chan
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 9.  Reactive oxygen species-activated nanomaterials as theranostic agents.

Authors:  Kye S Kim; Dongwon Lee; Chul Gyu Song; Peter M Kang
Journal:  Nanomedicine (Lond)       Date:  2015-09-02       Impact factor: 5.307

10.  Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

Authors:  C Iadecola; F Zhang; R Casey; M Nagayama; M E Ross
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.